Prevalence of skin lesions in familial adenomatous polyposis: A marker for presymptomatic diagnosis?

Oncologist

Volumn 16, Issue 12, 2011, Pages 1698-1705

  Burger, Bettina ^a   Cattani, Nadja ^a   Trueb, Swantje ^a   de Lorenzo, Rosaria ^a   Albertini, Mauro ^b   Bontognali, Emanuele ^b   Itin, Christoph ^c   Schaub, Nathalie ^d   Itin, Peter H ^a   Heinimann, Karl ^e  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Private practice ^*  (Switzerland)

^c Private practice   (Switzerland)

^d Private Practice   (Switzerland)

^e UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Cutaneous marker; Extracolonic manifestations; Familial adenomatous polyposis; Lipoma

Indexed keywords

APC PROTEIN;

ADULT; ARTICLE; CONGENITAL HYPERTROPHY OF THE RETINAL PIGMENT EPITHELIUM; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; EPIDERMOID CYST; FAMILIAL COLON POLYPOSIS; FEMALE; FIBROMA; GENE MUTATION; HUMAN; LIPOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OPHTHALMOSCOPY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA DISEASE; SKIN DEFECT; SKIN EXAMINATION;

ADENOMATOUS POLYPOSIS COLI; ADULT; CASE-CONTROL STUDIES; EPIDERMAL CYST; FEMALE; FIBROMA; GENES, APC; HETEROZYGOTE; HUMANS; LIPOMA; MALE; PIGMENT EPITHELIUM OF EYE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RETINAL DISEASES; SKIN NEOPLASMS;

EID: 84855182841     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2011-0244     Document Type: Article

References (45)

1. Groden J, Thliveris A, SamowitzWet al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991;66:589-600.
2. Bodmer WF, Bailey CJ, Bodmer J et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 1987;328: 614-616.
3. Kinzler KW, Nilbert MC, Su LK et al. Identification of FAP locus genes from chromosome 5q21. Science 1991;253:661-665.
4. Bülow S. Clinical features in familial polyposis coli. Results of the Danish Polyposis Register. Dis Colon Rectum 1986;29:102-107.
5. Bisgaard ML, Fenger K, Bülow S et al. Familial adenomatous polyposis (FAP): Frequency, penetrance, and mutation rate. Hum Mutat 1994;3: 121-125.
6. Vasen HF, Möslein G, Alonso A et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 2008;57:704-713.
7. Brocardo M, Henderson BR. APC shuttling to the membrane, nucleus and beyond. Trends Cell Biol 2008;18:587-596.
8. Davies DR, Armstrong JG, Thakker N et al. Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene. Am J Hum Genet 1995;57:1151-1158.
9. Lynch HT, Smyrk T, McGinn T et al. Attenuated familial adenomatous polyposis (AFAP). A phenotypically and genotypically distinctive variant of FAP. Cancer 1995;76:2427-2433.
10. Nieuwenhuis MH, Bülow S, Björk J et al. Genotype predicting phenotype in familial adenomatous polyposis: A practical application to the choice of surgery. Dis Colon Rectum 2009;52:1259-1263.
11. Caspari R, Olschwang S, Friedl W et al. Familial adenomatous polyposis: Desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet 1995;4:337-340.
12. Olschwang S, Tiret A, Laurent-Puig P et al. Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients. Cell 1993;75:959-968.
13. Coleman P, Barnard NA. Congenital hypertrophy of the retinal pigment epithelium: Prevalence and ocular features in the optometric population. Ophthalmic Physiol Opt 2007;27:547-555.
14. Enomoto M, Konishi M, Iwama T et al. The relationship between frequencies of extracolonic manifestations and the position of APC germline mutation in patients with familial adenomatous polyposis. Jpn J Clin Oncol 2000;30:82-88.
15. Gardner EJ, Richards RC. Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis. Am J Hum Genet 1953;5:139-147.
16. Fearnhead NS, Britton MP, Bodmer WF. The ABC of APC. Hum Mol Genet 2001;10:721-733.
17. Galiatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol 2006;101: 385-398.
18. Ascari-Raccagni A, Baldari U, Righini MG. Cutaneous symptoms of Gardner's syndrome. J Eur Acad Dermatol Venereol 1999;12:80-81.
19. Pujol RM, Casanova JM, Egido R et al. Multiple familial pilomatricomas: A cutaneous marker for Gardner syndrome? Pediatr Dermatol 1995;12: 331-335.
20. Bancroft LW, Kransdorf MJ, Peterson JJ et al. Benign fatty tumors: Classification, clinical course, imaging appearance, and treatment. Skeletal Radiol 2006;35:719-733.
21. Chen CS, Phillips KD, Grist S et al. Congenital hypertrophy of the retinal pigment epithelium (CHRPE) in familial colorectal cancer. Fam Cancer 2006;5:397-404.
22. Tiret A, Parc C. Fundus lesions of adenomatous polyposis. Curr Opin Ophthalmol 1999;10: 168-172.
23. Berk T, Cohen Z, McLeod RS et al. Congenital hypertrophy of the retinal pigment epithelium as a marker for familial adenomatous polyposis. Dis Colon Rectum 1988;31:253-257.
24. Morton DG, Gibson J, Macdonald F et al. Role of congenital hypertrophy of the retinal pigment epithelium in the predictive diagnosis of familial adenomatous polyposis. Br J Surg 1992;79: 689-693.
25. Itin PH, Heinimann K, Attenhofer M et al. Precalcaneal congenital fibrolipomatous hamartomas: Is there a pathogenetic relationship with Gardner syndrome? Eur J Dermatol 2010;20:246-247.
26. Walon C, Kartheuser A, Michils G et al. Novel germline mutations in the APC gene and their phenotypic spectrum in familial adenomatous polyposis kindreds. Hum Genet 1997;100:601-605.
27. Bisgaard ML, Bülow S. Familial adenomatous polyposis (FAP): Genotype correlation to FAP phenotype with osteomas and sebaceous cysts. Am J Med Genet A 2006;140:200-204.
28. Moisio AL, Järvinen H, Peltomäki P. Genetic and clinical characterisation of familial adenomatous polyposis: A population based study. Gut 2002;50:845-850.
29. Heinimann K, Müllhaupt B, Weber W et al. Phenotypic differences in familial adenomatous polyposis based on APC gene mutation status. Gut 1998;43:675-679.
30. Brensinger JD, Laken SJ, Luce MC et al. Variable phenotype of familial adenomatous polyposis in pedigrees with 3' mutation in the APC gene. Gut 1998;43:548-552.
31. Giardiello FM, Krush AJ, Petersen GM et al. Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation. Gastroenterology 1994;106: 1542-1547.
32. Bertario L, Russo A, Sala P et al. Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis. Int J Cancer 2001;95:102-107.
33. Leppard B, Bussey HJ. Epidermoid cysts, polyposis coli and Gardner's syndrome. Br J Surg 1975;62:387-393.
34. Kransdorf MJ. Benign soft-tissue tumors in a large referral population: Distribution of specific diagnoses by age, sex, and location. AJR Am J Roentgenol 1995;164:395-402.
35. Al-Khateeb TH, Al-Masri NM, Al-Zoubi F. Cutaneous cysts of the head and neck. J Oral Maxillofac Surg 2009;67:52-57.
36. Brenn T. Neoplasm of subcutaneous fat. In: Wolff K, Goldsmith LA, Katz SI et al., eds. Fitzpatrick's Dermatology in General Medicine, Seventh Edition. New York: McGraw-Hill Professional, 2007:1190.
37. Dei Tos AP, Dal Cin P. The role of cytogenetics in the classification of soft tissue tumours. Virchows Arch 1997;431:83-94.
38. Weiss SW, Goldblum JR. Enzinger and Weiss's Soft Tissue Tumors, Fourth Edition. St. Louis, MO: Mosby, 2001:1632.
39. Myhre-Jensen O. A consecutive 7-year series of 1331 benign soft tissue tumours. Clinicopathologic data. Comparison with sarcomas. Acta Orthop Scand 1981;52:287-293.
40. Rydholm A, Berg NO. Size, site and clinical incidence of lipoma. Factors in the differential diagnosis of lipoma and sarcoma. Acta Orthop Scand 1983;54:929-934.
41. Jung EG. [quot;Schnyder's rule" of heritability of skin tumors and its extension to cases of segmental presentation]. Hautarzt 1989;40:761-762.
42. Nieuwenhuis MH, Vasen HF. Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): A review of the literature. Crit Rev Oncol Hematol 2007;61: 153-161.
43. Plasilova M, Russell AM, Wanner A et al. Exclusion of an extracolonic disease modifier locus on chromosome 1p33-36 in a large Swiss familial adenomatous polyposis kindred. Eur J Hum Genet 2004;12:365-371.
44. Scott RJ, van der Luijt R, Spycher M et al. Novel germline APC gene mutation in a large familial adenomatous polyposis kindred displaying variable phenotypes. Gut 1995;36:731-736.
45. Sieber OM, Lamlum H, Crabtree MD et al. Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or "multiple" colorectal adenomas. Proc Natl Acad Sci U S A 2002;99:2954-2958.